Zev Schuman-Olivier, MD is the Executive Director and Research Director of the CHA Center for Mindfulness and Compassion, Medical Director for Addiction Services as well as Director of Addiction Residency Education and Mindful Mental Health Service at CHA. Dr. Schuman-Oliver is faculty in the Department of Psychiatry at Harvard Medical School and a faculty member in the Department of Biomedical Data Sciences at Geisel School of Medicine at Dartmouth. As a board-certified addiction psychiatrist, he has been involved with research and clinical care of patients with addiction, mental illness, and chronic pain both in mental health and primary care settings. He is a founding member of the Mindfulness Research Collaborative and is part of the NIH Science of Behavior Change Initiative. He is principal investigator of the MINDFUL-PC project, which is leading the way in integrating mindfulness into the patient-centered medical home. Prior to his psychiatry residency, he implemented the first federally-funded, randomized controlled trial of a mindfulness-oriented intervention for addictive disorders, and he is now principal investigator of the MINDFUL-OBOT trial, which is the first study to investigate the effects of mindfulness training in primary care office-based opioid treatment. He is Director of the Clinical Core for the NCCIH program project grant on synergistic approaches to chronic pain treatment. Finally, he led the development of the MySafeRx integrated technology platform and has been studying the impact of compassionate, motivational mobile recovery coaching and remote daily supervised medication dosing on medication adherence during opioid use disorder treatment.
Dr. Schuman-Olivier also presents locally, regionally and nationally on mindfulness for addictions treatment, and trains residents and peers on the topic.